It is common opinion that companies should focus on developing competitive items, not just simple generic items

It is analyzed that 'Golden Age of generic drug' is fading, because there are no striking original drugs such as Lipitor whose patent is expired. It is expected that there will be no more 'Generic blockbuster'. It is expected that unique generics with changing development patterns, changing the formulation will be competitive in the market.

We need to pay attention to some cases including Sami...